Anaeropharma: Anaeropharma, Chugai ink research agreement to create novel oncology drugs using Bifidobacterium
Anaeropharma Science Inc., a privately held biopharmaceutical company, and Chugai Pharmaceutical Co, Ltd have concluded a collaborative research agreement concerning the creation of novel oncology drugs
Read full article »
Anaeropharma is engaged in research and development of drugs for the treatment of hypoxic tumors.
Read more